Previous close | 9.31 |
Open | 9.30 |
Bid | 9.07 x 100 |
Ask | 9.11 x 4800 |
Day's range | 9.06 - 9.49 |
52-week range | 2.00 - 11.31 |
Volume | |
Avg. volume | 2,090,542 |
Market cap | 1.353B |
Beta (5Y monthly) | 1.31 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q4 2023 Clearside Biomedical Inc Earnings Call
The consensus price target hints at a 34.7% upside potential for Ocular Therapeutix (OCUL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
DEXTENZA Drives Revenue Increase as Company Focuses on Retinal Care